Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Certain drugs that block specific enzymes can help treat prostate diseases.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain hormone treatments can improve acne and related conditions in women.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Oral contraceptives may cause hair loss in women.